Unverified anecdotal reports from online forums mention various effects, though these cannot be confirmed without proper clinical investigation and may not represent causal relationships: Unverified reports of hormonal changes : Some users mention changes in libido or sexual function, though no causality has been established Theoretical cardiovascular concerns : Based on its purported vascular effects, though no clinical evidence exists Injection site reactions : Pain, redness, or swelling when administered subcutaneously Gastrointestinal symptoms : Nausea or abdominal discomfort in some reports Unknown long-term effects : No data exists on prolonged use or cumulative toxicity A significant safety concern involves product quality and contamination
There was no apparent effect of renal impairment, hepatic impairment or upper GI disease on the PK and tolerability of orally administered semaglutide, suggesting that dose adjustment is not necessary in these special populations [11, 31,32,33]
Over 39 months mean follow-up, the primary composite outcome of MACE (cardiovascular death, non-fatal MI, non-fatal stroke) dropped 20% in the semaglutide group
Where infiltration involves harmless fluids leaking into tissue, extravasation involves vesicant agents, medications that cause direct tissue damage when they escape the vein
Anticatabolic effects of ketone bodies in skeletal muscle
